Tag: Daniel Cohen
October 21, 2019
Aura Health Announces Name Change to Pharmadrug to Reflect Focus on Pharmaceutical Medicine
Aura Health Inc. ("Aura") (CSE:BUZZ, OTC:LMLLF) is pleased to announce that it has completed its name change from Aura Health...
October 9, 2019
Aura Health CEO: We’re Positioned to Capitalize on the German Cannabis Market
Aura Health CEO Daniel Cohen discusses his company’s progress in the European cannabis market, including the German medical cannabis market.
October 8, 2019
International Cannabis Industry Presenting Opportunity to Canadian Companies
Established Canadian producers are looking to expand into emerging international cannabis markets.
October 3, 2019
Aura Announces Extension of Maturity and Partial Repayment of Bridge Loan Facility
Aura Health Inc. is pleased to announce that the CAD$3 million bridge loan facility has been amended to mature in...
September 19, 2019
Aura’s Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution
Aura Health Inc. is pleased to announce a multi-year supply agreement between 80% owned subsidiary Pharmadrug Production GmbH and My...
August 13, 2019
Aura Announces Pharmadrug Operational & Investor Relations Update
Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ, OTCQB:LMLLF) is pleased to provide an operational update on Pharmadrug Production GmbH...
June 14, 2019